Charming Medical (MCTA) Long-Term Investments (2025 - 2026)

Charming Medical (MCTA) posted Long-Term Investments of $1.3 million for Q1 2026, up 265100.0% sequentially from $500.0 in Q3 2025, and up 265100.0% YoY from N/an in Q1 2025.

Charming Medical (MCTA) Long-Term Investments (2025 - 2026) Analysis & Trends

Charming Medical has reported Long-Term Investments for 2 years, with the latest figure at $1.3 million in Q1 2026.

  • Quarterly Long-Term Investments rose 265100.0% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 265100.0% YoY) and the FY2026 annual result came in at $1.3 million, up 265100.0% from the prior year.
  • Long-Term Investments improved to $1.3 million in Q1 2026 per MCTA's latest filing, from $500.0 in the prior quarter.
  • Over five years, Long-Term Investments peaked at $1.3 million in Q1 2026 and troughed at $500.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn 813.00 Mn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn 3.80 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn -
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn 183.80 Mn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn -
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn -
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn -
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn 148.15 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn -
10 Charming Medical 445.47 Mn 439.45 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.33 Mn
Sep 30, 2025 500.00
Mar 31, 2025 500.00